Europe Lung Cancer News
Europe
Europe Lung Cancer News is an EIN News Service for lung cancer professionals. Constantly updated news and information about Europe Lung Cancer.
Latest Europe Lung Cancer News
- Glance-Europe Factors-Shares seen up for 4th day; data eyed 15 Dec 2009 08:30 GMT
... LONDON, Dec 15 (Reuters) - European shares are set to advance for a ... benefits of a proposed new use for lung cancer pill Tarceva, documents released on Monday said. Maker ... Unilever. (Reporting by Atul Prakash) Keywords: MARKETS EUROPE FACTORS (atul.prakash@reuters.com; +44 20 7542 6189; Reuters ...
- Luther Allison - Songs From The Road 14 Dec 2009 17:50 GMT
... American, who have had to go to Europe in order for their music to be ... for others it has meant signing with European record companies. At one point in time ... Allison died only three years later from lung cancer just as he was re-establishing himself in North ...
- Luther Allison 14 Dec 2009 19:30 GMT
... American, who have had to go to Europe in order for their music to be ... for others it has meant signing with European record companies. At one point in time ... Allison died only three years later from lung cancer just as he was re-establishing himself in North ...
- Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10 Dec 2009 11:50 GMT
... 10 pharma company in the U.S., major Europe and globally. R&D pipeline boasts more than ... market share growth in nonsquamous non-small cell lung cancer (NSCLC). Outside the U.S., Alimta has grown 37 ... in many markets, including the major five European markets. Byetta was recently launched in China ...
- Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance (PRN) 10 Dec 2009 11:54 GMT
... growing in the United States and major Europe; the fourth-fastest growing in the pharmerging markets; ... market share growth in nonsquamous non-small cell lung cancer (NSCLC). Outside the U.S., Alimta has grown 37 ... in many markets, including the major five European markets. Byetta was recently launched in China ...
- Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 10 Dec 2009 11:57 GMT
... 10 pharma company in the U.S., major Europe and globally. -- R&D pipeline boasts more ... market share growth in nonsquamous non-small cell lung cancer (NSCLC). Outside the U.S., Alimta has grown 37 ... in many markets, including the major five European markets. Byetta was recently launched in China ...
- Lilly Outlines Innovation Strategy and Sets 2010 Financial Guidance 10 Dec 2009 13:33 GMT
... growing in the United States and major Europe; the fourth-fastest growing in the pharmerging markets; ... market share growth in nonsquamous non-small cell lung cancer (NSCLC). Outside the U.S., Alimta has grown 37 ... in many markets, including the major five European markets. Byetta was recently launched in China ...
- Lilly Outlines Innovation Strategy 10 Dec 2009 15:12 GMT
... 10 pharma company in the U.S., major Europe and globally. * R&D pipeline boasts more ... market share growth in nonsquamous non-small cell lung cancer (NSCLC). Outside the U.S., Alimta has grown 37 ... in many markets, including the major five European markets. Byetta was recently launched in China ...
- Lilly (Eli) & Co Lilly Outlines Innovation Strategy 10 Dec 2009 15:40 GMT
... 10 pharma company in the U.S., major Europe and globally. * R&D pipeline boasts more ... market share growth in nonsquamous non-small cell lung cancer (NSCLC). Outside the U.S., Alimta has grown 37 ... in many markets, including the major five European markets. Byetta was recently launched in China ...
- Novartis set to sustain its leading global position in oncology with portfolio targeting various tum 12 Dec 2009 18:11 GMT
... with 16 new molecular entities o Two US/EU oncology submissions on track for end-2009: Tasigna ... of market exclusivity for Diovan (hypertension) in Europe (2011) and the US (2012). "We have a productive ... disrupting agent being developed for non-small cell lung cancer (NSCLC). Two Phase III trials are evaluating ASA404 ...
- Novartis Seeks To Broaden Use Of Some Cancer Drugs 9 Dec 2009 07:12 GMT
... of market exclusivity for Diovan (hypertension) in Europe (2011) and the US (2012). "We have a productive ... planned to be submitted for US and EU approval for adjuvant use in certain types ... disrupting agent being developed for non-small cell lung cancer (NSCLC). Two Phase III trials are evaluating ASA404 ...
- Novartis set to sustain its leadi... 9 Dec 2009 13:50 GMT
... of market exclusivity for Diovan (hypertension) in Europe (2011) and the US (2012). "We have a productive ... planned to be submitted for US and EU approval for adjuvant use in certain types ... disrupting agent being developed for non-small cell lung cancer (NSCLC). Two Phase III trials are evaluating ASA404 ...
- Novartis set to sustain its leading global position in oncology with portfolio targeting various tumors and life-threatening diseases 9 Dec 2009 14:11 GMT
... with 16 new molecular entities * Two US/EU oncology submissions on track for end-2009: Tasigna ... of market exclusivity for Diovan (hypertension) in Europe (2011) and the US (2012). "We have a productive ... disrupting agent being developed for non-small cell lung cancer (NSCLC). Two Phase III trials are evaluating ASA404 ...
- Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost 9 Dec 2009 10:10 GMT
... amounted to over $1 billion in the European Union (EU), which includes total sales of ... Delivery Markets - Opportunity Analysis, and European Lung Cancer Therapeutics Markets. All research services included in subscriptions ... (M32D) Contact: Katja Feick Corporate Communications - Europe P: +49 (0) 69 7703343 E: katja.feick@frost.com ...
- Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 9 Dec 2009 10:11 GMT
... amounted to over $1 billion in the European Union (EU), which includes total sales of ... Delivery Markets - Opportunity Analysis, and European Lung Cancer Therapeutics Markets. All research services included in subscriptions ... ( Contact: Katja Feick Corporate Communications - Europe P: +49 (0) 69 7703343 E: ...
- Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9 Dec 2009 07:30 GMT
... Phase I/II clinical study of non-small cell lung cancer ("NSCLC") patients in Poland. Helix continues to develop ... continue to make preparations to conduct a European Phase III trial for this purpose, although ... clinical trials of Topical Interferon Alpha-2b in Europe. Income tax expense in the first quarter ...
- Memorial held after Cypriot president's body stolen 12 Dec 2009 14:50 GMT
... a year after the president died of lung cancer at age 74. Archbishop Chrysostomos II, head of ... newspaper said a Romanian gang active in Europe is a possible suspect. A family source ... failed and a divided island joined the European Union the same year. ...
- Memorial held after Cypriot leader's body stolen 12 Dec 2009 15:30 GMT
... a year after the president died of lung cancer at age 74. Archbishop Chrysostomos II, head of ... newspaper said a Romanian gang active in Europe is a possible suspect. A family source ... failed and a divided island joined the European Union the same year. ...
- Cyprus ex-president's remembered 12 Dec 2009 17:30 GMT
... a year after the president died of lung cancer at age 74. Archbishop Chrysostomos II, head of ... newspaper said a Romanian gang active in Europe is a possible suspect. A family source ... failed and a divided island joined the European Union the same year. Papadopoulos was defeated ...
- Cyprus ex-president remembered after tomb raid 12 Dec 2009 20:10 GMT
... a year after the president died of lung cancer aged 74. Archbishop Chrysostomos II, head of the ... newspaper said a Romanian gang active in Europe was a possible suspect. A family source ... failed and a divided island joined the European Union the same year. Papadopoulos was defeated ...
- Cyprus remembers former president 12 Dec 2009 23:13 GMT
... a year after the president died of lung cancer at age 74. Archbishop Chrysostomos II, head of ... newspaper said a Romanian gang active in Europe is a possible suspect. A family source ... failed and a divided island joined the European Union the same year. Papadopoulos was defeated ...
- Copenhagen 2009: An A-Z Guide 7 Dec 2009 00:53 GMT
... credits held by Russia and other eastern European countries that could flood carbon markets, if ... quite effective in reducing emissions, particularly in Europe - although this is due in part ... delay, progress; a chain-smoker, he died from lung cancer in 2005. In his heyday, Pearlman was dubbed ...
- First thoughts: Another crazy week 7 Dec 2009 15:37 GMT
... who said there's no proof smoking causes lung cancer. (Sent Monday, December 07, 2009 9:40 AM) ... by it. Only the US, Canada and Western Europe will be stupid enough to slit their own economic ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
|
a digital news provider
cbsnews.com:
reuters.com:
nytimes.com:
healthday.com: